An article titled “Cooling device reduces breast cancer-related alopecia during chemotherapy,” published Dec. 13, 2016, misstated the FDA status of the Orbis Paxman Hair Loss Prevention System. The device has received FDA clearance.
An article titled “Cooling device reduces breast cancer-related alopecia during chemotherapy,” published Dec. 13, 2016, misstated the FDA status of the Orbis Paxman Hair Loss Prevention System. The device has received FDA clearance.
EXPERT ANALYSIS AT THE NCCN ANNUAL CONFERENCE ORLANDO (FRONTLINE MEDICAL NEWS) – Referral to ...
AT OARSI 2017 LAS VEGAS (FRONTLINE MEDICAL NEWS) – The Osteoarthritis Research Society International ...
FROM JAMA Genetically corrected autologous skin grafts produced wound healing in a phase I ...
